Open Access. Powered by Scholars. Published by Universities.®

Social and Behavioral Sciences Commons

Open Access. Powered by Scholars. Published by Universities.®

Health Policy

2007

Childrens' Health

Articles 1 - 2 of 2

Full-Text Articles in Social and Behavioral Sciences

Achieving Family Health Literacy: The Case For Insuring Children, Sara J. Rosenbaum, Peter Shin, Barbara Debuono Jun 2007

Achieving Family Health Literacy: The Case For Insuring Children, Sara J. Rosenbaum, Peter Shin, Barbara Debuono

Health Policy and Management Faculty Publications

One aspect of the SCHIP reauthorization debate that has received more limited attention than it deserves is the relationship between children's health insurance coverage and family health literacy. That is, to what extent is children's health insurance associated with higher health literacy, and to what extent is reduced parental health literacy linked to lower rates of health insurance among children? This association is extremely important, since there is strong evidence of a link between health literacy and the appropriate use of health care. Evidence suggests that when previously uninsured children are covered by health insurance, parents at all income levels …


Assessing The Effects Of Federal Pediatric Drug Safety Policies, Avi Dor, Taylor Burke, Ramona Whittington, Taylor Clark, Ruth Lopert, Sara J. Rosenbaum Jun 2007

Assessing The Effects Of Federal Pediatric Drug Safety Policies, Avi Dor, Taylor Burke, Ramona Whittington, Taylor Clark, Ruth Lopert, Sara J. Rosenbaum

Health Policy and Management Faculty Publications

This policy analysis examines the effectiveness of pediatric exclusivity, one of the policy approaches the federal government uses to promote drug safety for children. Federal policy in this area is highly complex, and provisions related to pediatric drug safety, including pediatric exclusivity, are set to expire in 2007. Following a policy overview, this analysis summarizes the impact of pediatric exclusivity and reports on the results of our effort to shed light on the economic value of pediatric exclusivity. The analysis concludes with a discussion of options for further promoting a safe environment for drug use in children.